Moderate-to-severe Atopic Dermatitis Clinical Trials in Shenyang, Liaoning
2 recruitingShenyang, Liaoning, China
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis
Adolescents With Moderate-to-severe Atopic Dermatitis
Guangdong Hengrui Pharmaceutical Co., Ltd201 enrolled2 locationsNCT07309055
Recruiting
Phase 1Phase 2
A Phase Ib/II Study to Investigate the Safety of SHR-1819 in Children and Adolescents With Moderate-to-severe Atopic Dermatitis
Children and Adolescents With Moderate-to-severe Atopic Dermatitis
Guangdong Hengrui Pharmaceutical Co., Ltd50 enrolled1 locationNCT06713499